Company intelligence / Profile preview

Harvard Bioscience

Holliston, Massachusetts, United Statesharvardbioscience.com ↗

Ownership: Public · HBIO
Employees: ~500
Development stage: Other

Overview

Harvard Bioscience provides a broad portfolio of advanced instrumentation and software solutions supporting preclinical drug discovery, neuroscience, toxicology testing, organoid research, molecular analysis, cell analysis and bioprocessing. Its latest innovations include the Mesh MEA™ microelectrode array system for organoid applications and the SoHo™ implantable telemetry platform for real-time animal model monitoring. These products are widely adopted by academic labs as well as pharmaceutical/biotech companies to accelerate scientific discovery.

Modalities: DeviceSoftwareInstrumentationConsumables for laboratory research
Industry: Drug Discovery Services

Financials

Market cap: $35.9M
Total revenue: $22.7M
Enterprise value: $73.6M

Beyond the preview

Go deeper on Harvard Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harvard Bioscience.

Explore the full profile